Inventor · disambiguated record
Nadia Ahmad
Also filed as: AHMAD NADIA · AHMAD NADIA M · AHMAD NADIA MAMOONA
24 granted patents·13 pending applications·155 citations·filing 2008–2025
95Inventor score
Files withVERTEX PHARMA28AHMAD NADIA MAMOONA4X BIOTIX THERAPEUTICS INC2GLAXO GROUP LTD1KARUNA THERAPEUTICS INC1
Top patents by PatentIndex Score
37 records- 0197US9718827B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2016·Granted Aug 1, 2017·22 cites·6 claims
- 0297US9340546B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted May 17, 2016·57 cites·6 claims
- 0395US11834441B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Dec 5, 2023·4 cites·62 claims
- 0495US11827627B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Nov 28, 2023·3 cites·37 claims
- 0595US10647661B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted May 12, 2020·15 cites·106 claims
- 0694US11919887B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Mar 5, 2024·2 cites·21 claims
- 0794US9650381B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted May 16, 2017·19 cites·82 claims
- 0893US12247021B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 11, 2025·1 cites·24 claims
- 0993US11603351B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Mar 14, 2023·3 cites·27 claims
- 1093US10787452B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Sep 29, 2020·5 cites·20 claims
- 1192US9670215B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2015·Granted Jun 6, 2017·11 cites·3 claims
- 1291US12281057B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Apr 22, 2025·1 cites·15 claims
- 1390US2025223292A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1489US11117900B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2019·Granted Sep 14, 2021·2 cites·17 claims
- 1588US10392391B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Aug 27, 2019·4 cites·20 claims
- 1687US11370798B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·13 claims
- 1787US10800781B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Oct 13, 2020·2 cites·18 claims
- 1885US2025197381A1Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1984US10093676B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Oct 9, 2018·3 cites·19 claims
- 2082US12187731B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·19 claims
- 2180US12258333B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·22 claims
- 2273US12421242B2Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditionsKARUNA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·50 claims
- 2369US2025353836A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 2465US12465603B2Phthalazinone based modulators for the treatment of diseaseSOLEY THERAPEUTICS INC·Filed 2024·Granted Nov 11, 2025·0 cites·10 claims
- 2560US2024294512A1Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2659US12227475B2Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditionsX BIOTIX THERAPEUTICS INC·Filed 2022·Granted Feb 18, 2025·0 cites·21 claims
- 2758US2024400544A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2858US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2957US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3051US12440481B2Esters and carbamates as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
- 3150US12441703B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
- 3250US2025171400A1Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditionsX BIOTIX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3346US2010016399A1GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric DisordersAHMAD NADIA MAMOONA·Filed 2008·Application pending·0 cites
- 3446US2010048656A1Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disordersAHMAD NADIA MAMOONA·Filed 2008·Application pending·0 cites
- 3546US2010105713A1GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric DisordersGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 3645US2009325993A1GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric DisordersAHMAD NADIA MAMOONA·Filed 2008·Application pending·0 cites
- 3745US2012004273A1Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disordersAHMAD NADIA MAMOONA·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nadia Ahmad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →